Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
Clinical trial NCT02903069 · COMPLETED
Trial details
- NCT number
- NCT02903069
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-17
- Primary completion
- 2021-01-25
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.